News | June 04, 2026
Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US
The move signals a major expansion in access to next-generation weight-loss therapies
The move signals a major expansion in access to next-generation weight-loss therapies
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The approval introduces a needle-free alternative to injectable GLP-1 therapies
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial
The standout story remains Wegovy, particularly its new oral formulation
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
Operating profit fell 1% in Danish kroner to DKK 127.7 billion but rose 6% at constant exchange rates
Subscribe To Our Newsletter & Stay Updated
